Further research is needed to investigate whether hepatitis B vaccination protects against pneumococcal carriage by increasing the PCV13 antibody response or by an increased gene expression of IL8 and IL1B. Lastly, further investigations are needed to examine whether the antibody response to one specific serotype is depended on the carriage of another serotype. The gene discussed is IL1B; the disease is hepatitis B virus infection.